CWBC
Community West Bancshares
CWBC's outlook is improving, though it still trails on the overall score.
JPM
JPMorgan Chase & Co.
JPM has the edge over CWBC overall, supported by stronger fundamentals and stronger valuation.
CWBC Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| N/A | |
| N/A |
CWBC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like CWBC.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
CWBC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.1x | $12.74 | -50% |
| Forward | 8.9x | $25.64 | — |
| Fair | 10x | $16.28 | -37% |
| Expensive | 16x | $24.83 | -3.2% |
| Current | 16x | $25.64 | — |
Historical ranges are pointers, not guarantees.
CWBC's PE is in its expensive range at 16x. If earnings grow as analysts expect, today's price would be 8.9x next year's earnings, in its cheap range.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM has the edge over CWBC in the historical PE scenario, which offers more potential upside but is not a forecast.
CWBC Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
CWBC has the edge over JPM on the outlook, with more favorable valuation expectations.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
CWBC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.88 | +82% |
| Q3 2026 | $1.58 | -7.6% |
| Q2 2026 | $1.85 | +40% |
| Q1 2026 | $2.16 | +272% |
| Q4 2025 | $2.00 | +344% |
| Q3 2025 | $1.71 | +159% |
| Q2 2025 | $1.32 | +29% |
| Q1 2025 | $0.58 | -69% |
| Q4 2024 | $0.45 | -79% |
CWBC's earnings per share have fallen from their peak: $1.58 over the past year, against $2.35 in early 2023.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM's earnings per share have climbed steadily: $23.85 over the past year, up 18% from the year before, and higher year over year for 15 quarters in a row.
CWBC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $58M | +53% |
| Q2 2026 | $48.9M | +37% |
| Q1 2026 | $38.8M | +11% |
| Q4 2025 | $38.3M | +12% |
| Q3 2025 | $37.9M | +21% |
| Q2 2025 | $35.7M | +17% |
| Q1 2025 | $34.8M | +68% |
| Q4 2024 | $34.3M | +53% |
CWBC has the edge over JPM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 19% | -20 points |
| Q2 2026 | 8.5% | -22 points |
| Q1 2026 | 41% | +7.9 points |
| Q4 2025 | 40% | +11 points |
| Q3 2025 | 40% | +27 points |
| Q2 2025 | 30% | +56 points |
| Q1 2025 | 33% | +9.5 points |
| Q4 2024 | 29% | -5.5 points |
CWBC's operating margin was 19% last quarter, down 20 points from the same quarter a year ago.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over CWBC on profitability, with a higher operating margin.
CWBC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $17.9M | +40% |
| Q2 2026 | $17.5M | +65% |
| Q1 2026 | $8.2M | -24% |
| Q4 2025 | $9.5M | +$10.2M |
| Q3 2025 | $12.8M | +51% |
| Q2 2025 | $10.6M | +80% |
| Q1 2025 | $10.8M | +204% |
| Q4 2024 | -$701K | +$81K |
CWBC has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
CWBC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +35.7K shares |
| 1 year | +42% | +8.1M shares |
| 3 years | +131% | +15.4M shares |
| 5 years | +125% | +15.1M shares |
| Available history | +101% | +13.6M shares |
CWBC has 27M diluted shares, up 42% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $170,000 |
| Q1 2026 | $57,000 |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $71,000 |
| Q1 2025 | $80,000 |
| Q4 2024 | — |
CWBC has spent almost nothing on buybacks in the past year.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over CWBC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
CWBC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.5x | Net Cash |
| Q2 2026 | -0.6x | Net Cash |
| Q1 2026 | -1.6x | Net Cash |
| Q4 2025 | -0.9x | Net Cash |
| Q3 2025 | -2.0x | Net Cash |
| Q2 2025 | -1.2x | Net Cash |
| Q1 2025 | -0.7x | Net Cash |
| Q4 2024 | -3.6x | Net Cash |
CWBC has the edge over JPM on leverage, with a lower net debt burden relative to earnings.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
CWBC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.2 | Neutral |
| Stochastic | 44.2 | Neutral |
CWBC's weekly RSI is 51 (neutral) and its Stochastic is 44 (neutral).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
CWBC PE vs Financial Services Sector
| Metric | CWBC | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 13x | 25% above |
| PE % | 85 | 63 | 22 pts above |
CWBC is trading at 16x earnings, a 25% premium to the Financial Services sector's median of 13x.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM has the edge over CWBC on valuation relative to its sector.
CWBC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $26.0 | 1.5% below |
| 20 week MA | $26.1 | 1.6% below |
| 50 week MA | $24.7 | 3.9% above |
| 100 week MA | $22.1 | 16% above |
| 200 week MA | $20.3 | 27% above |
CWBC has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 27% above its 200-week average.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over CWBC on trend strength, trading above more of its moving averages.
CWBC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $21.7 | $15.1 | -31% |
| 2021 | $15.1 | $20.9 | +39% |
| 2022 | $20.9 | $20.8 | -0.1% |
| 2023 | $20.8 | $22.4 | +7.3% |
| 2024 | $22.4 | $19.4 | -13% |
| 2025 | $19.4 | $22.7 | +17% |
| 2026 YTD | $22.7 | $25.6 | +13% |
CWBC has the edge over JPM on returns for 2026, with the stronger performance.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.